Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Triflusal

InhA, Func 322-79-2
Catalog No. ABIN3222061
  • Application
    Inhibition Assay (InhA), Functional Studies (Func)
    Purpose
    Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
    Characteristics
    Source of Compound: synthetic
    Target: TXA2 antagonist,PDE inhibitor
    Receptor: PDE,TXA2R
    Purification
    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
    Purity
    97 %
    Formula
    C10H7F3O4
    Solubility
    DMSO 50 mg/mL, Water <1 mg/mL
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Solid
    Storage
    -20 °C
    Storage Comment
    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
    Expiry Date
    24 months
  • Background
    Angiogenesis,Metabolism
    Molecular Weight
    248.16 g/mol
    CAS-No
    322-79-2
You are here:
Support